The marijuana grower Aurora Cannabis is growing after his partner has been licensed to obtain a better quality of CBD (CBA)

Aurora Cannabis jumped more than 9% to $ 8.10 a share on Monday, after announcing that its technology partner, Radient Technologies, had received its standard Health Canada treatment license. Shares are trading at their highest level since Nov. 7.

According to Aurora, Radient's patented extraction technology can achieve much higher throughputs than is possible with existing reference technologies. It also has the effectiveness and ability to preserve the entire spectrum of cannabinoids and terpenes found in the source material, the company said.

"We realized early on that the ability to extract cannabis and hemp on a large scale while preserving quality would be a crucial competitive advantage in responding to the rapidly growing market for derivatives, such as vapespen solutions, capsules, edible products and beverages, "said Terry Booth, CEO of Aurora in a press release.

"With the upcoming new regulations allowing for additional form factors and the recent receipt of the Radient processor license, we are in a good position to rapidly develop the production of a broad portfolio of product – based products. excerpts, which corresponds well to the significant expansion of our We are looking forward to continuing to work closely with DenisTaschuk and his team at Radient to boost the accelerated growth of both companies. "

Other weed stocks were also up on Monday, including the Cronos Group (+ 8.64%), Aphria (+ 9.77%), Tilray (+ 7.58%) and Canopy Growth (+ 1.7%).

Aurora has recently attracted the attention of Millennials. In September 2018, Bloomberg announced that Coca-Cola was in discussion with Aurora to develop beverages infused with Cannabidiol (CBD), one of the non-psychoactive compounds found in cannabis. An agreement never succeeded.

But it was only the beginning. In October, following the official legalization of marijuana for recreational purposes in Canada, Aurora became public on the New York Stock Exchange.

Since then, it has intensified its expansion into the US market, where the regulatory framework has become more favorable for marijuana growers.

On January 14, less than a month after the adoption of the Farm Bill, which legalized hemp, a popular ingredient source, cannabidiol, Aurora told Business Insider that it planned to produce CBD derived from hemp for the US market in the coming months.